{"favorite_id": 10310, "calc_type": "diagnostic_criteria", "dosing": false, "full_title_en": "Rome IV Diagnostic Criteria for Fecal Incontinence", "short_title_en": "Rome IV for Fecal Incontinence", "medium_description_en": "Official Rome IV criteria for the diagnosis of fecal incontinence.", "short_description_en": "Fecal incontinence diagnosis.", "before_use": "", "instructions_en": "<p dir=\"ltr\">Use in patients with recurrent fecal staining or uncontrolled passage of stool for the past 3 months.</p>\n<p dir=\"ltr\">Do NOT use in patients with:</p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-2d9e6a15-7fff-e092-cf2d-3fd176783ca5\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Clear mucous secretion alone.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Remote, isolated episodes of fecal incontinence.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Developmental age &lt;4 years old or before toilet training has occurred.</p>\n</li>\n</ul>", "purpose_en": ["Diagnosis"], "disease_en": ["Functional Anorectal Disorders", "Disorders of Gut-Brain Interaction (DGBI)"], "specialty_en": ["Family Practice", "Gastroenterology", "Hospitalist Medicine", "Internal Medicine", "Primary Care"], "chief_complaint_en": ["Fecal Incontinence"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Rome IV Criteria for Fecal Incontinence, Rome IV for Fecal Incontinence, rome iv fecal incontinence, rome iv for incontinence, rome iv incontinence, fecal incontinence, incontinence, fecal incontinence rome, fecal incontinence rome iv, rome incontinence, rome 4 for fecal incontinence, rome 4 fecal incontinence, rome 4 incontinence"], "slug": "rome-iv-diagnostic-criteria-fecal-incontinence", "seo": {"meta_description_en": "The Rome IV Criteria for Fecal Incontinence provides criteria for diagnosis of fecal incontinence.", "keywords_en": "Rome IV Criteria for Fecal Incontinence, Rome IV for Fecal Incontinence, rome iv fecal incontinence, rome iv for incontinence, rome iv incontinence, fecal incontinence, incontinence, fecal incontinence rome, fecal incontinence rome iv, rome incontinence, rome 4 for fecal incontinence, rome 4 fecal incontinence, rome 4 incontinence"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-48eff1d9-7fff-61af-a998-9573353052a0\">Use in patients with recurrent fecal staining or uncontrolled passage of stool for the past 3 months.</p>", "pearls_pitfalls_en": "<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Patients often will not volunteer this symptom and rapport is critical.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Rule out if fecal staining of underwear is due to poor hygiene rather than true fecal incontinence.</p>\n</li>\n</ul>\n<p></p>\n<p dir=\"ltr\">Important clinical questions:</p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Awareness of need to stool (i.e. rectal urgency) prior to incontinence episodes?</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong></strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">If not aware = passive incontinence.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">If aware but unable to reach toilet in time = urge incontinence.</p>\n</li>\n</ul>\n</li>\n</ol>\n<ol start=\"2\">\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Occasional large hard stools with leakage of small liquid stool without awareness?</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong></strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Suggestive of fecal retention and overflow incontinence.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Use <calculator id=\"10017\">Bristol Stool Chart</calculator> to clarify.</p>\n</li>\n</ul>\n</li>\n</ol>\n<ol start=\"3\">\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Characterization of incontinence?</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong></strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Type (solid, liquid, and/or gas).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Timing (during/after events such as meals, exercise, nocturnal).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Severity/quantity (seepage &lt; staining &lt; soiling of underwear, clothing, bedding).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Frequency.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Impact on quality of life.</p>\n</li>\n</ul>\n</li>\n</ol>\n<p></p>\n<p dir=\"ltr\">Important risk factors:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Laxatives, artificial sweeteners, magnesium supplements, lactose.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anorectal surgeries.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Prior obstetric procedures/complications and multi-parity.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Constipating agents leading to fecal retention and overflow.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Secondary causes: multiple sclerosis, diabetic neuropathy, Parkinson&rsquo;s, scleroderma, rectal prolapse, central nervous system disorders (e.g. dementia, stroke, brain tumors, spinal cord lesions), bile acid associated diarrhea.</p>\n</li>\n</ul>\n<p></p>\n<p dir=\"ltr\">Thorough digital rectal exam is critical:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Assess if anal &ldquo;wink&rdquo; reflex absent suggestive of neurologic damage.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Assess anal pressures when patient resting, squeezing, and simulating defecation.</p>\n</li>\n</ul>\n<p></p>\n<p dir=\"ltr\">NOTE: Nocturnal incontinence is more frequently associated with other conditions affecting GI motility (diabetes, scleroderma, etc).</p>", "why_use_en": "<p><span id=\"docs-internal-guid-338a59ac-7fff-18cb-1cf9-06c45a593b77\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fecal incontinence can have significant impact on quality of life.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Frequently under-reported symptom requiring adept clinical history taking.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Multi-factorial disease process often requiring multidisciplinary management approach.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Passive incontinence suggests internal anal sphincter pathology.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Urge incontinence suggests external anal sphincter pathology.</p>\n</li>\n</ul>\n<p dir=\"ltr\">If diagnosis confirmed, consider multifactorial causes:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Anal sphincter weakness:</strong></p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Traumatic: obstetric, surgical.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Non-traumatic: scleroderma, internal sphincter degeneration.</p>\n</li>\n</ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Neuropathy: </strong>peripheral (pudendal nerve) or generalized (diabetes).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Pelvic floor disorder: </strong>rectal prolapse, descending perineum syndrome.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Decreased rectal capacity:</strong></p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Inflammatory: radiation proctitis, Crohn&rsquo;s, ulcerative colitis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Anorectal surgery (pouch, anterior resection).</p>\n</li>\n</ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Central nervous system disease: </strong>dementia, stroke, tumors, multiple sclerosis, spinal cord lesions.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><strong>Bowel disturbances:</strong></p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Irritable bowel syndrome, functional diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Constipation with overflow incontinence, especially when associated with fecal impaction.</p>\n</li>\n</ul>\n</ul>", "management_en": "<p dir=\"ltr\"><strong>If symptoms mild/limited impact on quality of life:</strong></p>\n<p dir=\"ltr\">Consider conservative measures:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Avoid reversible factors (laxatives, artificial sweeteners, certain medications etc).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dietary trial to reduce diarrhea (psyllium-based fiber, diet low in lactose or fermentable oligo-, di-, monosaccharides and polyols [FODMAPs]).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Loperamide 2-4 mg as needed 30 minutes before meals or social occasions where bathroom access limited, up to 16 mg/day.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Low dose tricyclic antidepressant (e.g. 25 to 50 mg/day), improves continence in patients with diarrhea-associated incontinence.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">For Incontinence-Associated Dermatitis (IAD) avoiding soap and application of leave-on products (moisturizers, skin protectants, or a combination) seems to be more effective than withholding these products.</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>If fecal retention and overflow:</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Empty the colon and place patient on a regular bowel regimen.&nbsp;</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>If symptoms are moderate/severe and impact quality of life or not responding to symptomatic treatment:</strong></p>\n<p dir=\"ltr\">Frequently requires more diagnostic testing:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Flexible sigmoidoscopy or colonoscopy (i.e. microscopic colitis, Ulcerative Proctitis).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anorectal manometry +/- rectal sensation testing.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anal ultrasound: can guide surgical repair.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Pelvic MRI: especially if possible rectovaginal pathology.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Defecography (Conventional, MRI): useful in select patients with fecal incontinence if structural cause of outlet obstruction suspected (e.g. large rectocele, rectal prolapse, or excessive perineal descent).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Electromyography (EMG): especially urge incontinence.</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>Often requires multidisciplinary management approach:</strong></p>\n<p><span id=\"docs-internal-guid-f2684f19-7fff-b1ca-fab7-9b4d377cfb84\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Pelvic floor physical therapy: biofeedback therapy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Minimally invasive techniques: sacral nerve stimulation, anal submucosal injection of bulking agent.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Colorectal surgery: reconstruction of anal sphincter defects or colostomy (last resort).</p>\n</li>\n</ul>", "critical_actions_en": "<p><span id=\"docs-internal-guid-f8bf9a3a-7fff-a272-eedd-b4dfc5b397c2\">Assessment and diagnosis of fecal incontinence requires careful history taking, careful digital rectal exam and often further testing. Management plan should be directed through addressing the underlying etiology in conjunction with addressing the severity of symptoms and impact on quality of life. </p>"}, "about": {"formula_en": "<p>To fulfill the Rome IV criteria for fecal incontinence,* patient must have the following for 3 months prior (for research studies, consider onset of symptoms for &ge;6 months&nbsp;prior with 24 episodes of FI over 4 weeks):</p>\n<ol>\n<li>Recurrent uncontrolled passage of fecal material in an individual with a developmental age of&nbsp;&ge;4 years.</li>\n</ol>\n<p>*Defined as the recurrent uncontrolled passage of fecal material for&nbsp;&ge;3 months.</p>", "more_info_en": "", "evidence_based_medicine_en": "<p dir=\"ltr\">Given the heterogeneity of anorectal physiologic testing, in January 2020 an international consensus group outlined a testing protocol to help standardize anorectal manometry procedures worldwide. Over 90% of experts agreed that anorectal manometry was indicated for assessment of fecal incontinence symptoms to identify and quantify anal sphincter impairment and abnormal rectal sensitivity. Decreased anal resting pressure (anal hypotension) with or without decreased anal squeeze pressure (anal hypocontractility) were considered major findings not seen in asymptomatic adults. Both rectal hyposensitivity and hypersensitivity were also classified as major findings.&nbsp;</p>\n<p><span id=\"docs-internal-guid-d9a4c57d-7fff-1bcd-fb35-3c22445beac9\"></p>\n<p dir=\"ltr\">In 2014, the American College of Gastroenterology published guidelines for the management of benign anorectal disorders recommended nonsurgical treatments for patients with fecal incontinence such as education, dietary modifications, skin care, and pharmacologic agents to modify bowel habits and stool consistency such as loperamide for diarrhea and bowel regimens for constipation with suspected overflow incontinence. If conservative measures fail and especially if surgical therapy is considered, further testing should be considered such as anal ultrasound, pelvic MRI, defecography, and pelvic floor EMG. Pelvic floor rehabilitation including biofeedback were strongly recommended. Other minimally invasive procedures such as injectable anal bulking agents and surgical treatments such as sacral nerve stimulation and anal sphincteroplasty could also be considered, however currently multi-center randomized controlled trials are underway to determine head to head efficacy.</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035713/", "text": "Rao SS, Bharucha AE, Chiarioni G, et al. Functional Anorectal Disorders. Gastroenterology. 2016; 150: 1430-1442."}], "Other References": [{"href": "https://pubmed.ncbi.nlm.nih.gov/25022811/", "text": "Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014 Aug;109(8):1141-57."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002467/", "text": "Van meegdenburg MM, Meinds RJ, Trzpis M, Broens PMA. Subtypes and symptoms of fecal incontinence in the Dutch population: a cross-sectional study. Int J Colorectal Dis. 2018;33(7):919-925."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"name": "Justin Brandler, MD"}]}, "creator": [{"name": "Dr. Douglas Drossman", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Douglas Drossman, MD, is professor emeritus of medicine and psychiatry at the University of North Carolina School of Medicine. He is founder, President Emeritus and Chief of Operations of the Rome Foundation. He is also the founder of the Drossman Center for the Education and Practice of Biopsychosocial Care and Drossman Consulting, LLC. Dr. Drossman has written over 500 articles and book chapters, has published two books, a GI procedure manual and a textbook of functional GI disorders (Rome I-IV), and serves on six editorial and advisory boards.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-douglas-drossman.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Drossman+DA%5BAuthor%5D"}}, {"name": "Dr. Lin Chang", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Lin Chang, MD is responsible for the oversight and coordination of the Rome IV calculators on MDCalc. She is a Professor of Medicine at the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA and is a member of the Rome Foundation Board of Directors.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lin-chang.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Chang+L+%5Bauthor%5D"}}, {"name": "The Rome Foundation", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>The <a href=\"https://theromefoundation.org\" target=\"_blank\" rel=\"noopener\">Rome Foundation</a> is an independent not for profit 501(c) 3 organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of Disorders of Gut-Brain Interaction (DGBI), also known as functional gastrointestinal (GI) disorders. Their mission is to improve the lives of people with DGBI. Over the last 3 decades, the Rome organization has sought to legitimize and update our knowledge of the DGBIs. This has been accomplished by bringing together scientists and clinicians from around the world to classify and critically appraise the science of GI function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice. Diagnosis is based on the use of <a href=\"https://theromefoundation.org/rome-iv/rome-iv-criteria/\" target=\"_blank\" rel=\"noopener\">symptom-based criteria</a> which are used in clinical trials and daily practice. The list of Rome IV categories and the Chair and Co-Chair of each chapter committee are listed below.</p>\n<table border=\"\\&quot;0\\&quot;\" collapse;=\"\" width:=\"\" 100%;\\\"=\"\">\n<tbody>\n<tr>\n<td 31.1628%;\\\"=\"\"><strong>Committees</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Chair</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Co-Chair</strong></td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Esophageal Disorders</td>\n<td 31.3097%;\\\"=\"\">Ronnie Fass, MD</td>\n<td 31.3097%;\\\"=\"\">John Pandolfino, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gastroduodenal Disorders</td>\n<td 31.3097%;\\\"=\"\">Nicholas J. Talley, MD, PhD, FRACP</td>\n<td 31.3097%;\\\"=\"\">Vincenzo Stanghellini, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Bowel Disorders</td>\n<td 31.3097%;\\\"=\"\">Fermin Mearin, MD</td>\n<td 31.3097%;\\\"=\"\">Brian Lacy, MD, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gallbladder and Sphincter of Oddi Disorders</td>\n<td 31.3097%;\\\"=\"\">Grace Elta, MD</td>\n<td 31.3097%;\\\"=\"\">Peter Cotton, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Centrally Mediated Disorders of Gastrointestinal Pain</td>\n<td 31.3097%;\\\"=\"\">Peter J. Whorwell, MD</td>\n<td 31.3097%;\\\"=\"\">Laurie Keefer, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Anorectal Disorders</td>\n<td 31.3097%;\\\"=\"\">Adil E. Bharucha, MD, MBBS</td>\n<td 31.3097%;\\\"=\"\">Satish S. C. Rao, MD, PhD, FRCP</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Neonate/Toddler</td>\n<td 31.3097%;\\\"=\"\">Sam Nurko, MD</td>\n<td 31.3097%;\\\"=\"\">Marc A. Benninga, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Child/Adolescent</td>\n<td 31.3097%;\\\"=\"\">Carlo Di Lorenzo, MD</td>\n<td 31.3097%;\\\"=\"\">Jeffrey S. Hyams, MD</td>\n</tr>\n</tbody>\n</table>\n<p><b>Rome IV Diagnostic Criteria Chapters, Chairs and Co-Chairs</b></p>\n<p><b>Rome IV Editorial Board:</b> Douglas A. Drossman, MD, Senior Editor, Lin Chang, MD, William D. Chey, MD, John Kellow, MD, Jan Tack, MD, PhD, and William E. Whitehead, PhD.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/rome-foundation.png", "pubmedLink": "undefined"}}], "reviewer": {"expert_name": [{"name": "Max J. Schmulson W., MD"}]}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "Must have the following:", "subheading_instructions": "For 3 months prior", "type": "subheading"}, {"type": "toggle", "label_en": "Recurrent uncontrolled passage of fecal material in an individual with a developmental age of \u22654 years", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "one"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 10332, "short_title_en": "Rome IV for Child Fecal Incontinence", "slug": "rome-iv-diagnostic-criteria-child-non-retentive-fecal-incontinence"}, {"calcId": 10323, "short_title_en": "Rome IV for Proctalgia Fugax", "slug": "rome-iv-diagnostic-criteria-proctalgia-fugax"}, {"calcId": 10283, "short_title_en": "Rome IV for Functional Dysphagia", "slug": "rome-iv-diagnostic-criteria-functional-dysphagia"}]}